ClinicalTrials.gg
RecruitingNCT06262074Updated Feb 15, 2024

Effect of Structured Training Program in Diabetic Patients

An interventional study of Structured Exercise Program and Non structured exercise program in Diabetic Peripheral Neuropathy, sponsored by Maharishi Markendeswar University (Deemed to be University). Recruiting at 1 site in India. Open to participants aged 40 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-15.

Sponsored by Maharishi Markendeswar University (Deemed to be University) · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2024; still recruiting 2 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 70 Years
Sex
All
01

Study summary

Diabetic neuropathy, a challenging condition resulting from poorly managed type-1 or type-2 diabetes mellitus, often proves resistant to conventional medications when it comes to alleviating the associated symptoms. In such cases, implementing a well-organized exercise regimen has proven beneficial in mitigating diverse symptoms associated with the condition and enhancing the overall quality of life for affected individuals.

Read the detailed description

The goal of this type of interventional study is to assess the effect a well-defined exercise program for individuals with DPN, despite the existence of various individualized exercise programs designed for DPN patients. The main questions this study aims to answer is:

What is the effect of a 4-weeks structured training program as an adjunct to general lower limb exercise in patients with DPN on pain, sensory symptoms, balance, vibration sense and Quality of life?

Group 1:

Patients in group 1 will receive a structured exercise program.

Group 2:

Patients in group 2 will receive a non-structured exercise program. This group will allow us to compare the effects of a structured and a non-structured exercise program.

02

Conditions studied

  • Diabetic Peripheral Neuropathy
03

In context

Lead sponsor

Maharishi Markendeswar University (Deemed to be University) is the lead sponsor of 41 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diabetes mellitus with moderate to severe DPN
  • Subjects of both gender
  • Age from 40 to 70 years
  • Independent walking
  • MNSI score more than 2 out of 13

Exclusion criteria

Exclusion Criteria:

  • Presence of an active planter ulcer
  • History of surgery during intervention period
  • Neurological diseases other than DPN
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group-1 (Structured Exercise Program)

    Patients undergo structured exercise sessions lasting 30 minutes, encompassing activities such as range of motion, flexibility exercises, strength training, balance exercises, and aerobic exercises, with designated intervals between each session.

    Other: Structured Exercise Program

  • Other
    Group-2 (Non-Structured Exercise Program)

    Patients are provided with a simple exercise routine that lacks a structured format.

    Other: Non structured exercise program

Interventions

  • OtherStructured Exercise Program

    30 minutes of structured exercise programs

  • OtherNon structured exercise program

    Non structured exercises

06

What researchers measure

Primary outcomes

  1. Michigan neuropathy screening instrument (MNSI)

    The scale consists of two parts: the first part involves a patient history assessment, while the second part focuses on physical examination. This scale is considered both reliable and practical for evaluating the severity of neuropathy. If the patient's score increases, it indicates a higher severity of the disease, whereas if the score decreases, it suggests a lower severity.

    Time frame: The measurement will be taken during the baseline assessment and again after the completion of treatment.

  2. Biothesiometer

    This objective measure is utilized to assess the vibratory pressure threshold in affected areas. It possesses the capability to detect various frequencies for vibratory pressure threshold assessment. It is regarded as a practical tool for evaluating both superficial and vibratory sensations. If there is an increased perception of frequency, it indicates that the vibratory pressure threshold is more severely affected.

    Time frame: The measurement will be taken during the baseline assessment and again after the completion of treatment.

  3. NeuroQoL

    The Neuropathy-and Foot-Ulcer Specific Quality of Life Instrument is designed as a Likert scale and serves as a reliable method for assessing quality of life related to neuropathy. If the scoring indicates a higher value, it suggests that the disease is more severe.

    Time frame: The measurement will be taken during the baseline assessment and again after the completion of treatment.

Secondary outcomes

  1. NPRS

    The Numeric Pain Rating Scale, ranging from 0 to 10, is employed as a subjective assessment tool to measure an individual's pain perception. In general, higher scores on the scale indicate a greater severity of pain linked to the disease.

    Time frame: The measurement will be taken during the baseline assessment and again after the completion of treatment.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06262074
Lead sponsor
Maharishi Markendeswar University (Deemed to be University)
Responsible party
Subhasish Chatterjee (Clinical Professor, Maharishi Markendeswar University (Deemed to be University)) — Principal investigator
First posted
Feb 15, 2024
Start date
Feb 8, 2024
Primary completion
Feb 8, 2024
Completion
Mar 31, 2024 (estimated)
Last update
Feb 15, 2024

Study contacts

Subhasish Chatterjee, PhD
Contact
subhasishphysio@mmumullana.org
8708660994
Khushboo Kumari, BPT (MPT)
Contact
physio.khushboo11@gmail.com
08718089830
Khushboo Kumari, BPT, (MPT)
principal investigator · Maharishi Markandeshwar Instirtute of Physiotherapy and Rehabilitation, Ambala, Haryana, 133207

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion